| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1439-7633(20020104)3:1<61::AID-CBIC61>3.0.CO;2-I |
| P8608 | Fatcat ID | release_au6h7duap5b27e5vt7lyffopr4 |
| P698 | PubMed publication ID | 17590955 |
| P2093 | author name string | Carlos Alonso | |
| Carmen Navarro-Ranninger | |||
| Annie Schwartz | |||
| José M Pérez | |||
| Miguel A Fuertes | |||
| Eva I Montero | |||
| Jean M Malinge | |||
| Marc Leng | |||
| P2860 | cites work | A new method for sequencing DNA | Q24605576 |
| Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure | Q28260454 | ||
| X-Ray structure of cytotoxic trans-[PtCl(2)(dimethylamine)(isopropylamine)]: interstrand cross-link efficiency, DNA sequence specificity, and inhibition of the B-Z transition. | Q31402705 | ||
| Current status of the development of trans-platinum antitumor drugs | Q33998355 | ||
| DNA double helix promotes a linkage isomerization reaction in trans-diamminedichloroplatinum(II)-modified DNA. | Q35685036 | ||
| Sequence preferences of DNA interstrand crosslinking agents: quantitation of interstrand crosslink locations in DNA duplex fragments containing multiple crosslinkable sites | Q35761618 | ||
| DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues | Q36351000 | ||
| Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. | Q37422551 | ||
| Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA. | Q38344920 | ||
| Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: relationship to toxicity | Q39681354 | ||
| Intrastrand cross-links are not formed in the reaction between transplatin and native DNA: relation with the clinical inefficiency of transplatin | Q40394674 | ||
| Apoptosis induction and inhibition of H-ras overexpression by novel trans-[PtCl2(isopropylamine)(amine')] complexes | Q40907859 | ||
| Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells | Q40924467 | ||
| Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity | Q41146945 | ||
| Structure, Recognition, and Processing of Cisplatin-DNA Adducts. | Q55035583 | ||
| DNA Adducts of cis-Diamminedichloroplatinum(II) and Its Trans Isomer Inhibit RNA Polymerase II Differentially in Vivo | Q71786418 | ||
| DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II) | Q72551702 | ||
| Cellular and molecular determinants of cisplatin resistance | Q77809152 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 61-67 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Apoptosis induction and DNA interstrand cross-link formation by cytotoxic trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2) : cross-linking between d(G) and complementary d(C) within oligonucleotide duplexes | |
| P478 | volume | 3 |
| Q35565981 | Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer Chemotherapy |
| Q37276239 | Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes |
| Q37576021 | Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm |
| Q34565192 | Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds? |
| Q46865307 | Syntheses and characterization of vitamin B12-Pt(II) conjugates and their adenosylation in an enzymatic assay |
| Q28066801 | The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs |
| Q40089378 | Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription. |
Search more.